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SurgicalSolutions
Thoracic & Esophageal Surgery
Program Combines Nationwide Expertise
with Robotic, Telehealth Innovations
focused on Thoracic Outlet Syndrome.
Common among athletes, this condition
may develop when the muscles at the
top of the chest become so enlarged
that they pinch the nerves, arteries and
veins coming out of the chest.

Our surgeons use the da Vinci® Surgical System, which provides a magnified, high-definition 3-D image of the
patient’s anatomy and translates the surgeon’s hand movements into precise micro-movements.

The Jefferson Thoracic & Esophageal
Surgery Program offers a full range of
services with an emphasis on robotic
procedures (90% of cases) – increasing
the likelihood of a shorter hospital stay
and a faster overall recovery. Led by
Nathaniel R. Evans III, MD, the Program
is comprised of surgeons Scott W.
Cowan, MD, Tyler R. Grenda, MD, MS,
and Olugbenga T. Okusanya, MD, as
well as nurse practitioner, Sung E.
Whang, DNP, CRNP.
Robotic approaches can be especially
beneficial for lung cancer patients.
When performing lobectomies and
segmentectomies with this technology,
surgeons are able to spare more
healthy lung tissue.
“These techniques provide patients
optimal breathing function after
surgery,” Dr. Evans explains. The team
also uses robotic methods to treat
esophageal cancer and hiatal hernias,
including very large hernias of the
stomach into the chest.
The Program is part of an enterprise
multidisciplinary group, which includes
gastroenterologists and general
surgeons and looks at all types of
complex esophageal cancer, as well
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as benign esophageal diseases and
conditions, such as reflux and hiatal
hernias.

Along with robotics,
the Program has also
been an early adopter of
telemedicine. Even before
the COVID-19 pandemic,
the team led the way
in using virtual visits to
engage with patients.
Dr. Evans notes that one of the
Program’s strengths is the diversity of
its team’s education and experience.
Having been trained at institutions
from coast to coast, these surgeons
bring perspectives from some of the
largest thoracic surgery programs in
the country. For example, Dr. Grenda is
an expert in revision foregut surgery –
that is, correcting previously treated
hernias that recur a second or third
time. In addition, Dr. Okusanya came to
Jefferson from the nation’s leading
Minimally Invasive Esophagectomy
program and is also initiating a program

Along with robotics, the Program
has also been an early adopter of
telemedicine. Even before the
COVID-19 pandemic, the team led the
way in using virtual visits to engage with
patients. In 2018, Dr. Whang received
the JeffConnect Healthcare Delivery &
Quality Transformation Award for
facilitating 149 video visits with post-op
patients over a 12-month period.
“Because of that early experience,
it was easy for us to transition fully to
telehealth visits earlier this year,” Dr.
Evans says, adding that the program
completed 567 telehealth visits from
mid-March to mid-December. Dr.
Grenda reported that experience in the
August 2020 issue of the Annals of
Surgery.
“There were multiple patients that we
‘met’ via video visit to review the plan
and the imaging studies that needed
to be done prior to their surgery. We
wouldn’t physically meet them until
the day of the surgery.”
One such patient first presented in
the Emergency Department with
COVID-19. Only through that diagnosis
was she found to have lung cancer.
After a virtual visit with Dr. Evans, she
was scheduled for a robotic right upper
lobectomy – a procedure that
successfully removed the cancerous
tissue and confirmed she had stage
IIB disease. She spent just one night
in the hospital and following an
uncomplicated recovery, she was
treated with adjuvant therapy.
To schedule an appointment with a
thoracic surgeon or refer a patient,
please call 215-955-5562.
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The Surgeon Speaks

“Our team is committed to exploring and
adopting new and better ways of caring
for our patients. That’s evident both in the
surgical techniques we use and the ways in
which we engage with patients.
It’s also clear in our research priorities.
One example is a recent clinical trial on
immunotherapy for early-stage lung cancer.
This represents the new frontier for
immunotherapy, which currently focuses
on metastatic or late-stage disease.
In another study, we’re collecting lung
cancer samples to explore the potential to
create a blood test for lung cancer. This
involves drawing blood from patients with
and without lung cancer and then assessing
their micro-RNA to identify potential signs
of cancer.
We’re being mindful to include patients of
all ethnic backgrounds to ensure our results
are applicable to the real-world – including
the diverse base of patients that we care for
at Jefferson.”
Nathaniel R. Evans III, MD
Professor of Surgery
Director, Division of Thoracic &
Esophageal Surgery

For more information, please visit:
JeffersonHealth.org/Korman
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Overview

New Faculty
Charles J. Yeo, MD, FACS
Samuel D. Gross Professor and Chairman
Department of Surgery
Senior Vice President and Chair, Enterprise Surgery
Jefferson Health

Resilience
Resilience is defined as the “the capacity to recover quickly from
difficulties; toughness”. Psychologists define resilience as the ability
to adapt well in the face of trauma, tragedy, adversity or significant
sources of stress. While medical school, nursing school and postgraduate training all require some measure of adaptability for
learners, little of the past has prepared us for 2020: the COVID-19
pandemic, the economic downturn, multiple episodes of racial
injustice and a toxic political environment.
The response of Jefferson Health and Jefferson Surgery this past
year has been nothing short of miraculous. With the initial COVID19 surge in the spring of 2020 we quickly adapted to a new normal.
N95 masks. Face shields. COVID-19 testing. We were nimble
enough to resume our full OR schedules in a few short months.
Our ORs were quite busy. Our ICUs were at or near capacity. What
we were no longer doing as face-to-face patient encounters in
the office setting we replaced with telehealth visits. To quote Jodi
Picoult from My Sister’s Keeper: “The human capacity for burden is
like bamboo – far more flexible that you would ever believe at first
glance.”
I have never been more proud of Jefferson Surgery than I was this
year. The entire Department deserves huge KUDOs. We have cared
for large numbers of very ill patients (some with COVID-19); we
have seen an increased volume of trauma patients; our cardiac
surgery, thoracic surgery and transplant surgery teams have been
very busy; and our cancer patient population has been maintained.
A departing thought, from Winston Churchill: “If you’re going
through hell, keep going”. We have kept going!

Jessica Latona, MD,
has joined the Division
of Acute Care Surgery.
Dr. Latona completed
the General Surgery
Residency Program and
Surgical Critical Care Fellowship at
Thomas Jefferson University Hospital.
She also completed a Research
Fellowship at Lankenau Hospital.
Susanna Nazarian, MD,
PhD, FACS, has joined
the Division of General
Surgery. Dr. Nazarian
completed the General
Surgery Residency, PhD
Program in Clinical Investigation, and
Abdominal Organ Transplantation
Fellowship at Johns Hopkins. She
recently completed a Breast Cancer
Surgery Fellowship at University of
Pennsylvania.
Radu A. Nedelcoviciu,
MD, FACS, has joined
the Division of Acute
Care Surgery. Dr.
Nedelcoviciu completed
the General Surgery
Residency at Lankenau Hospital. He
then completed the Surgical Critical
Care and Trauma Fellowship at
University of Miami/Jackson Memorial
Hospital. He is board certified in
Surgery and Surgical Critical Care.

Michael Nooromid, MD,
has joined the Division
of Vascular and
Endovascular Surgery.
Dr. Nooromid
completed the Vascular
Surgery Integrated Residency at
Northwestern Memorial Hospital.
Olugbenga Okusanya,
MD, FACS, has joined
the Division of Thoracic
and Esophageal Surgery.
Dr. Okusanya
completed the General
Surgery Residency and served as a
Research Fellow at the Hospital of the
University of Pennsylvania. He then
completed Cardiothoracic Surgery
Residency and Minimally Invasive
Thoracic Surgery Fellowship at the
University of Pittsburgh Medical
Center. He specializes in minimally
invasive thoracic and esophageal
surgery.

Meet the Interns
Last June, in the midst of the COVID-19 pandemic, the
following sixteen categorical interns began their training
in our three General Surgery Residency Programs.
Thomas Jefferson University Hospital

Fari Fall, MD
Albert Einstein College of Medicine

Luke Meredith, MD
University of Louisville
School of Medicine

Emily Isch, MD
University of Connecticut
School of Medicine

Sourav Podder, MD
University of Massachusetts
Medical School

Kathleen Jarrell, MD
Sidney Kimmel Medical College

Hamza Rshaidat, MD*
St. George’s University of London Sidney Kimmel Medical College

*Two of our interns are graduates of a unique transatlantic partnership between St. George’s, University
of London, and Sidney Kimmel Medical College at Thomas Jefferson University. The program, initiated
in 2015, was designed to allow students to prepare for 21st century global health challenges via
exposure to both U.S. and U.K. health systems.

Abington – Jefferson Heatlh

Jaleesa Akuoko, MD
Geisel School of Medicine
at Dartmouth

Christian DiLiberto, DO
Rowan University School of
Osteopathic Medicine

Rowan University School of Osteopathic
Medicine & Jefferson Health System

Nielsen Gabriel, DO
Touro University of Nevada College
of Osteopathic Medicine

Fareed Hamidulla, DO
Rowan University School of
Osteopathic Medicine

Dean Granot, MD
Sidney Kimmel Medical College

Monica Khattak, DO
Rowan University School of
Osteopathic Medicine

Robert Myers, MD
University of Texas Southwestern
Medical Center at Dallas

Tyler Sauerbeck, DO
Ohio University Heritage College of
Osteopathic Medicine

Casey Paterson, MD*
St. George’s University of London Sidney Kimmel Medical College

Victoria Tiedemann, DO
Touro College of Osteopathic
Medicine - New York

Clinical Integration

Changing Lives Through Research

‘Dragon Heart’ Holds
Promise as Flexible,
Cost-Effective Treatment
for Heart Failure

General Surgery Continues Journey
as Enterprise Service Line

Drs. Amy Throckmorton (on sabbatical from Drexel University) and Vakhtang Tchantchaleisvilli are collaborating
locally on a new cardiac assist and replacement device as part of a national team funded by NIH. The laboratory is
located in the College Building on Walnut Street.

Could congestive heart failure (CHF)
be treated with a total artificial heart
that contains just two moving parts?
That’s one of the questions that
cardiac surgeon, Vakhtang
Tchantchaleishvili, MD, and biomedical
engineer Amy L. Throckmorton, PhD,
an associate professor at the Drexel
University School of Biomedical
Engineering, Science and Health
Systems, are collaborating to answer.
Known as “Dragon Heart,” the device
they are testing is an advanced cardiac
assist and replacement technology
designed and developed by Dr.
Throckmorton, who is currently on
sabbatical at Jefferson. She and Dr.
Tchantchaleishvili are part of a national
team that in July 2020 secured a fouryear, $1.5 million research grant from
the National Heart, Lung, and Blood
Institute within the National Institutes
of Health to support this pre-clinical
development phase.
If proven effective, the Dragon Heart
would offer a compact, multifunctional total artificial heart that
could help both adult and pediatric
patients with CHF. To do so, it relies
on two moving parts: an axial impeller
for pulmonary circulation and a
centrifugal impeller for systemic
circulation.
CHF is a costly disease in terms of
human and financial impact. This
progressive and debilitating disease
affects about 5.1 million people in the
United States alone, with about
670,000 new cases diagnosed every
year. Treating patients with CHF costs
the healthcare industry more than
$35 billion annually, and existing
treatments, including transplantation,

are not always available or effective
for all patients.
“My vision of the Dragon Heart has
been to provide as much versatility as
possible in giving clinical management
teams the ability to offer the right
treatment for the right patient at the
right time,” says Dr. Throckmorton,
who used pump design equations,
computational modeling, and
benchtop prototype testing to inform
device design and performance.
The Dragon Heart has been designed
to support the left or right side of the
heart, to partially support both
ventricles, or to fully support both
ventricles as a total artificial heart,
providing a viable alternative to heart
transplantation. Dr. Tchantchaleishvili
puts it even more succinctly –
referring to the Dragon Heart as
“the Batmobile of cardiac assist and
replacement technologies.”
Dr. Tchantchaleishvili says the device is
also noteworthy because of its use of
full magnetic levitation technology,
one of most recent innovations in
cardiac replacement technology.
“The Dragon Heart is one of only
three total artificial hearts that are
continuous-flow devices,” he says.
“This device also supports pulsatile
flow, adding to its clinical versatility.”
While at Jefferson, Dr. Throckmorton
is continuing to build prototypes of
the Dragon Heart and is working
with Dr. Tchantchaleishvili, H. Todd
Massey, MD, Surgical Director, Cardiac
Transplantation and Mechanical
Circulatory Support, and others to
prepare for additional studies of the
device’s efficacy.

As Jefferson Health has grown to
include 14 acute-care hospitals, the
system continues to make the strategic
shift from “holding company” to
“operating company.” The General
Surgery service line – which includes
all services within the Department of
Surgery except for Cardiac, Thoracic,
Transplant and Vascular – has made
significant progress in the journey to a
truly enterprise approach.

“For example, a surgeon from one of our
hospitals may have a recommendation
for a new surgical service, device or
technique,” says Messer, who assumed
administrative responsibility for the
General Surgery service line last
December. “We’re now evaluating such
proposals at the enterprise level. Based
on the idea’s merits, we may decide to
put it on pause, or we may opt to deploy
it across the service line.”

With the General Surgery service line
formally established in October 2019,
surgical leaders from across Jefferson
Health have converged around shared
strategic planning and clinical and
operational support.

In addition to the ISFP, the General
Surgery service line is working to create
a series of Clinical Pathways (CPs)
to establish consistency in surgical
patient diagnosis, treatment and
follow-up. Each CP will outline the most
appropriate, evidence-based standard of
care that every Jefferson Health surgeon
should follow when delivering a specific
procedure.

“Greater communication and
transparency are critical when making
a shift to an enterprise model. There is
always more work to do, but we have
made great progress,” says Charles J.
Yeo, MD, who leads the service line in
his capacity as Senior Vice President
and Chair, Enterprise Surgery, Jefferson
Health. Other General Surgery leaders
include Mohammad I. Khan, MD, Vice
Chair at Jefferson Health – Northeast,
Orlando Kirton, MD, Vice Chair at
Jefferson Health – Abington, Roy L.
Sandau, DO, Vice Chair at Jefferson
Health – New Jersey, and Francesco
Palazzo, MD, Vice Chair at Jefferson
Methodist Hospital.
As Vice President and Service Line
Administrator Adam Messer explains,
the Integrated Strategic Financial
Planning (ISFP) process is serving as
the formal process and mechanism
to ensure that general surgeons are
operating not as individual physicians
or hospitals, but as an enterprise.

“I’m thankful to be collaborating with
Dr. Tchantchaleishvili and his team to
complete the critical acute testing
studies in animals,” Dr. Throckmorton
says. “These are a necessary step
toward achieving successful
translation of the Dragon Heart
blood pump technology. His

“Think of Clinical Pathways as a guardrail
around a particular clinical episode
that ensure we have consistently good
outcomes,” Messer says. “We want to use
evidence and consensus to ensure that
no matter who your surgeon is or where
your surgery is performed, you’ll have
the same type of care.”
Messer notes that the upcoming
enterprise launch of the Epic electronic
medical record (EMR) system to include
all Jefferson Health hospitals will be
critical enabler for CPs.
“The 2021 launch of Epic will put
everyone on the same integrated EMR
from inpatient to outpatient and will
be a foundational tool for developing
CPs and establishing enterprise-wide
standards of care,” Messer concludes.

research team at Jefferson is ideally
suited to lead and conduct these
animal studies.”
For more information, please visit:
Research.Jefferson.edu/labs/
researcher/tchantchaleishvililaboratory.html

For an appointment with a Jefferson Surgeon, call 1- 800-JEFF-NOW

Those Who Give

Swoyers Support Colorectal Cancer Vaccine Research
While COVID-19 vaccines are dominating the
headlines, a pair of Jefferson researchers
remain focused on preventing another disease:
colorectal cancer. Scott Waldman, MD, PhD,
Samuel M.V. Hamilton Professor, and Adam
Snook, PhD, Assistant Professor of
Pharmacology and Experimental Therapeutics,
have developed an adenovirus-vector vaccine
that works by prompting an immune response
specifically to a colorectal cancer tumor
antigen called guanylyl cyclase (GUCY2C), first
identified by Dr. Waldman in 1994. This
research will now benefit from a generous gift
by grateful patient Lorraine Swoyer, and her
husband of 40 years, David.

Lorraine and David Swoyer at Congress Park in
Saratoga Springs, NY, for their son’s wedding in
June 2016

It’s been more than two years since Lorraine,
now 62, was diagnosed with colon cancer. A
month after the diagnosis, a friend of the family
put them in touch with Charles J. Yeo, MD,
FACS, Samuel D. Gross Professor and Chair of
Surgery, to get a recommendation for a
surgeon. In short order they were meeting with
Director of Colorectal Surgery, Scott D.

Goldstein, MD, FACS, who ultimately removed
the tumors in Lorraine’s colon, along with
numerous lymph nodes for further evaluation.
As part of her treatment, Lorraine also worked
with medical oncologist, Edith P. Mitchell, MD,
MACP, FCPP. She underwent six months of
chemotherapy, which concluded in January
2019. Since then, she has been under close
surveillance and is rapidly approaching the
two-year mark of being cancer free.
Lorraine gives high praise to every physician
and nurse she encountered during her
experience as a Jefferson patient.
“Everyone was phenomenal,” she says. “They
were very attentive and explained everything.
I felt comfortable asking my nurses anything.”

She’s also energized by the progress Jefferson
is making on preventing and treating colorectal
cancer, and happy to be able to support it.

Lorraine says she’s less quiet now than she was
before her experience with cancer.

“When we toured the lab and heard about what
they’re doing, we decided to donate to get this
vaccine to the finish line and hopefully save
someone else from going through a similar
ordeal,” Lorraine recalls.

“I’m not embarrassed by it,” she says. “I want to
be open about it and help other people going
through it. Emotional support is such an
important part of the healing process.”

To learn more about supporting cancer and
surgical research, contact Kelly Austin at
215-955-6383 or kelly.austin@jefferson.edu.
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Now that she’s recovered, Lorraine is back to
enjoying life with her husband and grown sons.
One son owns and operates a restaurant with
his wife in Saratoga Springs, New York; the
other son was recently married. While they
await grandchildren, she and Dave enjoy
visiting and renovating their home at the Jersey
Shore. When the pandemic restrictions ease up,
they hope to travel frequently – especially
since Dave recently announced his retirement
from banking.
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News in Brief
Karen Chojnacki, MD (General Surgery), Nathaniel Evans
III, MD (Thoracic Surgery), and Alliric Willis, MD (General
Surgery), have each been promoted to Professor of Surgery.

Stanton Miller, MD, MPH (Acute Care
Surgery), has been promoted to Clinical
Associate Professor of Surgery.

Charles J. Yeo, MD, received a 2020 GLOBY
Award for Corporate Leadership presented
by the Global Philadelphia Association.

Theresa Yeo, PhD, MPH, ACNP-BC, AOCNPBC, was awarded an inaugural Advanced
Practice Providers Excellence Award for
Clinical Research at Jefferson Health.

On November 14, patients/survivors (pictured) and their
friends and family logged in from 167 different locations to
attend our 15th Annual (1st Virtual) Pancreatic Cancer and
Related Disease Patient Symposium.
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